LEUPRORELIN (PROSTAP 3 DCS ®)

Clinical Indication

Breast cancer

Comments

3 monthly preparation

Date of classification

June 2021

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .